Xiaohong Lu

Dr. Xiaohong Lu is a cancer research specialist at Newcastle University with extensive contributions to molecular oncology, particularly in p53 signaling pathways and neuroblastoma research. Her collaborative work spans multiple departments within the university's medical research ecosystem.

Her research focuses on transcriptional regulation in cancer, with specialization in:

• MDM2-p53 protein interactions and inhibitor development
• MYC/MYCN oncoprotein targeting strategies
• Mechanisms of DNA damage response in tumor cells
• Neuroblastoma-specific therapeutic approaches

Analysis of her publication history (2000-2016) reveals consistent emphasis on protein-protein interaction inhibitors and oncogene-targeted therapies, particularly through scaffold-hopping methodologies and structural optimization of small molecules. Her most recent work explores radiation sensitivity in drug-resistant cancer models.

Dr. Lu has maintained long-term collaborations with Professor John Lunec's research group and other Newcastle oncology experts, contributing to significant advancements in cancer drug discovery pipelines. Her laboratory work primarily utilizes human tumor cell line models for mechanistic studies and therapeutic validation.